Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children
NCT ID: NCT03772119
Last Updated: 2024-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2019-02-04
2039-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical treatment of hemivertebra
cohort of children with a vertebral malformation treated by surgical resection
Surgical resection
Surgical resection of hemivertebra
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical resection
Surgical resection of hemivertebra
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with a vertebral malformation requiring surgery for hemivertebras
Exclusion Criteria
* Different procedure of a surgical resection of vertebral malformation
* Absence of medical follow-up
* Parents refusal concerning data storage
3 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry ODENT, MD-PhD
Role: STUDY_DIRECTOR
University Hospttal, Tours
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Surgery Service, University Hospital, Bordeaux
Bordeaux, , France
Pediatric Surgery Service, University Hospital, Grenoble
Grenoble, , France
Pediatric Surgery Service, University Hospital, Lyon
Lyon, , France
Pediatric Surgery Service, University Hospital, Marseille
Marseille, , France
Pediatric Surgery Service, University Hospital, Nantes
Nantes, , France
Pediatric Surgery Service, University Hospital, Nice
Nice, , France
Pediatric Surgery Service, University Hospital, Armand Trousseau Hospital, AP-HP
Paris, , France
Pediatric Surgery Service, Robert-Debré Hospital, AP-HP
Paris, , France
Pediatric Surgery Service, University Hospital, Necker Hospital, AP-HP
Paris, , France
Pediatric Surgery Service, University Hospital, Rennes
Rennes, , France
Pediatric Surgery Service, University Hospital, Saint-Etienne
Saint-Etienne, , France
Pediatric Surgery Service, University Hospital, Toulouse
Toulouse, , France
Pediatric Surgery Service, University Hospital, Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yan LEFEVRE, MD-PhD
Role: primary
Aurélien COURVOISIER, MD-PhD
Role: primary
Thierry HAUMONT, MD-PhD
Role: primary
Vincent CUNIN, MD
Role: backup
Sébastien PESENTI, MD-PhD
Role: primary
Antoine HAMEL, MD-PhD
Role: primary
Federico SOLLA, MD
Role: primary
Raphael VIALLE, MD-PhD
Role: primary
Brice ILHARREBORDE, MD-PhD
Role: primary
Keyvan MAZDA, MD-PhD
Role: backup
Lofti MILADI, MD
Role: primary
Philippe VIOLAS, MD-PhD
Role: primary
Elie HADDAD, MD
Role: primary
Bruno DOHIN, MD-PhD
Role: backup
Franck ACCADBLED, MD-PhD
Role: primary
Thierry ODent, MD-PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIPH3-RNI17/HEMIVERTEBRE SOFOP
Identifier Type: -
Identifier Source: org_study_id